Anders A. Jensen

Anders A. Jensen is a Professor in the Department of Drug Design and Pharmacology at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Molecular and Cellular Pharmacology. His research focuses on receptor pharmacology, particularly calcium-sensing receptors and serotonin 5-HT2A receptors, with significant contributions to understanding receptor modulation and drug development.

Professor Jensen's research interests span molecular pharmacology, drug design, and receptor signaling mechanisms. His work particularly emphasizes calcium homeostasis disorders, allosteric modulation of receptors, and the development of novel compounds targeting serotonin receptors for neurological conditions. He has made significant contributions to understanding the structure-function relationships of G protein-coupled receptors and their implications for drug discovery.

Analysis of his recent publications reveals a strong focus on receptor pharmacology with particular emphasis on calcium-sensing receptors and serotonin 5-HT2A receptors. His research spans both basic molecular mechanisms and translational applications, with work ranging from nanobody development to novel therapeutic compounds for pain management and depression. The publications demonstrate expertise in receptor kinetics, structure-activity relationships, and the molecular basis of receptor-related disorders.

Professor Jensen maintains active research collaborations across multiple institutions and has founded and directs Drug Design and Pharmacology at Lophora (www.lophora.com), though this is noted as a separate activity from his university employment. His research output includes 194 publications with significant impact in pharmacology and related fields.